|
Cardiovascular medicine
Citations 1161-1170 of 25895 total displayed.
|
Past content
(since Oct 1840):
|
-
- Editorials
- The trouble with dabigatran
- Blake Charlton and Rita Redberg
-
BMJ 2014;349:g4681, doi: 10.1136/bmj.g4681,
-
[Extract]
[Full text]
[PDF]
-
- Feature
- Concerns over data in key dabigatran trial
- Deborah Cohen
-
BMJ 2014;349:g4747, doi: 10.1136/bmj.g4747,
-
[Extract]
[Full text]
[PDF]
-
- Editorials
- Mass treatment with statins
- Ben Goldacre and Liam Smeeth
-
BMJ 2014;349:g4745, doi: 10.1136/bmj.g4745,
-
[Extract]
[Full text]
[PDF]
-
- RESEARCH NEWS
- Niacin fails to reduce vascular events in large randomised trial
- Michael McCarthy
-
BMJ 2014;349:g4774, doi: 10.1136/bmj.g4774,
-
[Full text]
[PDF]
-
- Endgames
- More than just a simple fracture
- Mohammed Monem and Alex Trompeter
-
BMJ 2014;349:g4600, doi: 10.1136/bmj.g4600,
-
[Extract]
[Full text]
[PDF]
-
- Letters
- We could all learn from Brazils Family Health Program
- Matthew J Harris
-
BMJ 2014;349:g4693, doi: 10.1136/bmj.g4693,
-
[Extract]
[Full text]
[PDF]
-
- News
- Indian cardiologists plan campaign to reduce unnecessary investigations
- Cheryl Travasso
-
BMJ 2014;349:g4740, doi: 10.1136/bmj.g4740,
-
[Extract]
[Full text]
[PDF]
-
- Research
- Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients
- Daniel Keene, Clare Price, Matthew J Shun-Shin, and Darrel P Francis
-
BMJ 2014;349:g4379, doi: 10.1136/bmj.g4379,
- [Abstract]
[Full text]
[PDF]
-
- Editorials
- Not so "good" cholesterol
- Leonard Kritharides
-
BMJ 2014;349:g4664, doi: 10.1136/bmj.g4664,
-
[Extract]
[Full text]
[PDF]
-
- News
- NICE sticks to its advice to drop threshold for prescribing statins
- Nigel Hawkes
-
BMJ 2014;349:g4694, doi: 10.1136/bmj.g4694,
-
[Extract]
[Full text]
[PDF]
|